期刊文献+

血栓弹力图对经皮冠状动脉介入治疗术后支架内再狭窄的预测价值 被引量:5

Predictive value of thrombelastogram to in-stent restenosis after percutaneous coronary intervention
下载PDF
导出
摘要 目的研究血栓弹力图对经皮冠状动脉介入治疗(PCI)术后支架内再狭窄的预测价值。方法采用病例对照研究方法,选自2013年8月~2014年8月于安阳地区医院诊断为PCI术后1年内支架内再狭窄的患者作为病例组(18例),同时选择PCI术后1年未发生支架内再狭窄的患者作为对照组(50例),观察两组之间血小板聚集抑制率是否存在差异,与PCI术后再狭窄的发生有无统计学关联,是否为其发生的独立危险因素。结果病例组ADP途径血小板抑制率低于对照组,差异有统计学意义(P<0.05),与PCI术后再狭窄的发生独立相关,OR值为2.063。结论血小板抑制率与PCI术后支架内再狭窄发生独立相关,ADP途径血小板抑制率不达标为PCI术后患者发生再狭窄的独立危险因素。 Objective To study the predictive value of thrombelastogram(TEG)to in-stent restenosis after percutaneous coronary intervention(PCI).Methods The patients(n=18)with in-stent restenosis within1y after PCI(case group)and patients(n=50)without in-stent restenosis within1y after PCI(control group)were chosen by applying case-control study method from the Anyang Region Hospital from Aug.2013to Aug.2014.The difference in degree of platelet aggregation inhibition(DPAI)between2group,statistical correlation between DPAI and instent restenosis after PCI and whether DPAI was independent risk factor of in-stent restenosis or not were observed.Results DPAI in ADP way was lower in case group than that in control group(P<0.05),and it was independently correlated to the incidence of in-stent restenosis after PCI(OR=2.063).Conclusion DPAI is independently correlated to the incidence of in-stent restenosis after PCI,and lower DPAI in ADP way is an independent risk factor of in-stent restenosis after PCI.
作者 杨晓红 郝增光 郑晓晖 YANG Xiao-hong;HAO Zeng-guang;ZHENG Xiao-hui(Second Department of Cardiology, Anyang Region Hospital, Henan Province, 455000 Anyang, China)
出处 《中国循证心血管医学杂志》 2017年第4期424-426,共3页 Chinese Journal of Evidence-Based Cardiovascular Medicine
基金 濮阳市科技攻关项目(140639)
关键词 血栓弹力图 PCI术后再狭窄 预测价值 Thrombelastogram Restenosis after percutaneous coronary intervention Predictive value
  • 相关文献

参考文献7

二级参考文献88

  • 1黄震华.急性冠脉综合征预防进展[J].中国新药与临床杂志,2004,23(8):552-555. 被引量:16
  • 2田静文,方颖,周爱英.急性冠脉综合征初期他汀类药物短期治疗对内皮功能的影响[J].中国药业,2004,13(12):65-67. 被引量:25
  • 3蒙碧波,吕传柱,蒋宜颖.经皮冠状动脉介入治疗急性冠脉综合征的进展[J].中华急诊医学杂志,2005,14(8):696-698. 被引量:5
  • 4Stanworth SJ,Dyer C,Choo L,et al.Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions:background,rationale,and design of a clinical trial(trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions[J].Trans Med Rev,2009,24(3):163-171.
  • 5Avvisati G,Tirindelli MC,Annibali O.Thrombocytopenia and hemorrhagic risk in cancer patients[J].Cirit Rev Oncol Hematol,2003,48(S):13-16.
  • 6Webert KE,Cook RJ,Sigouin CS,et al.The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia[J].Haematological,2006,91(11):1530-1537.
  • 7Slichter SJ.Relationship between platelet count and bleeding risk in thrombocytopenic patients[J].Trans Med Rev,2004,18(3):153-167.
  • 8Reikvam H,Steien E,Hauge B,et al.Thrombelastography[J].Trans Apher Sci,2009,40(2):119-123.
  • 9Roeloffzen WWH,Kluin-Nelemans HC,Mulder AB,et al.In normal controls,both age and gender affect coagulability as measured by thrombelastography[J].Anesth Analg,2010,110(4):987-994.
  • 10Ng KF.Changes in thrombelastograph vriables associated with aging[J].Anesth Analg,2004,99(2):449-454.

共引文献166

同被引文献55

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部